{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T07:10:52Z","timestamp":1726384252434},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2023,5,1]]},"DOI":"10.1001\/jamaophthalmol.2023.1114","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T15:00:59Z","timestamp":1679497259000},"page":"497","source":"Crossref","is-referenced-by-count":3,"title":["Potential Rare Danger of Presumably Benign Artificial Tears"],"prefix":"10.1001","volume":"141","author":[{"given":"Christina R.","family":"Prescott","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Grossman School of Medicine, New York University Langone Health, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Colby","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Grossman School of Medicine, New York University Langone Health, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"eic230016r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2023.1105","article-title":"Pseudomonas aeruginosa corneal ulcer associated with artificial tears eye drops.","author":"Morelli","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eic230016r3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.18502\/jovr.v14i3.4781","article-title":"Outbreak of multidrug-resistant pseudomonas aeruginosa endophthalmitis due to contaminated trypan blue solution.","volume":"14","author":"Bawankar","year":"2019","journal-title":"J Ophthalmic Vis Res"},{"issue":"10","key":"eic230016r5","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3390\/pharmaceutics14102176","article-title":"Highlighting the microbial contamination of the dropper tip and cap of in-use eye drops, the associated contributory factors, and the risk of infection: a past-30-years literature review.","volume":"14","author":"Iskandar","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"eic230016r7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1001\/jamaophthalmol.2020.2810","article-title":"Retinal vasculitis after administration of brolucizumab resulting in severe loss of visual acuity.","volume":"138","author":"Kondapalli","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"24","key":"eic230016r8","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1001\/jama.295.24.2867","article-title":"An outbreak of Fusarium keratitis associated with contact lens wear in Singapore.","volume":"295","author":"Khor","year":"2006","journal-title":"JAMA"},{"key":"eic230016r1","unstructured":"ErziCare. Accessed March 1, 2023. https:\/\/ezricare.com\/"},{"key":"eic230016r4","unstructured":"US Centers for Disease Control and Prevention. Outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with artificial tears. Accessed February 26, 2023. https:\/\/www.cdc.gov\/hai\/outbreaks\/crpa-artificial-tears.html"},{"key":"eic230016r6","unstructured":"US Food and Drug Administration. Global pharma healthcare issues voluntary nationwide recall of artificial tears lubricant eye drops due to possible contamination. Accessed February 25, 2023. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/global-pharma-healthcare-issues-voluntary-nationwide-recall-artificial-tears-lubricant-eye-drops-due"},{"key":"eic230016r9","unstructured":"US Food and Drug Administration. Over-the-counter monograph M018: Ophthalmic drug products for over-the-counter human use. Accessed March 6, 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/omuf\/OTC%20Monograph_M018-Ophthalmic%20Drug%20Products%20for%20OTC%20Human%20Use%2004.04.22.pdf"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2802948\/jamaophthalmology_prescott_2023_ic_230016_1686788941.47011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T01:00:31Z","timestamp":1686790831000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2802948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.1114","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}